cp 96345 has been researched along with Magnesium Deficiency in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mak, IT; Phillips, TM; Weglicki, WB | 1 |
| Cassidy, MM; Dickens, BF; Mak, IT; Phillips, TM; Stafford, RE; Weglicki, WB | 1 |
2 other study(ies) available for cp 96345 and Magnesium Deficiency
| Article | Year |
|---|---|
Blockade of cardiac inflammation in Mg2+ deficiency by substance P receptor inhibition.
Topics: Animals; Biphenyl Compounds; Calcitonin Gene-Related Peptide; Cytokines; Glutathione; Magnesium Deficiency; Male; Myocardium; Neuropeptides; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Substance P; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha | 1994 |
Neurogenic peptides and the cardiomyopathy of magnesium-deficiency: effects of substance P-receptor inhibition.
Topics: Animals; Biphenyl Compounds; Cardiomyopathies; Cytokines; Magnesium Deficiency; Neurokinin-1 Receptor Antagonists; Neuropeptides; Rats; Rats, Sprague-Dawley | 1994 |